source
- Matchpoint Therapeutics raises $150M Series B to advance oral covalent therapies for autoimmune diseaseMatchpoint Therapeutics announced a $150 million Series B financing round. The round was co-led by Nextech Invest and Norwest, with participation from Sanofi Ventures, Digitalis Ventures, Invus, BB…
- Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companiesForbion announced a record fundraising of €2.3 bn ($2.6 bn) across two new funds, bringing its assets under management to about €7.5 bn ($8.4 bn). The capital will be allocated through the Forbion…